Conference Description

Registration is closed for this course.

September 13, 2008
Sheraton Raleigh
421 South Salisbury Street
Raleigh, NC

Tell a friend about this conference

Release Date: September 13, 2008

Expiration Date: September 13, 2008

Estimated Time To Complete CME Activity: 4.0 Hours

Medium/Method: Live Conference

Hardware/Software Requirements: None

CME Credits: 4.0*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:
New Perspectives in the Management of Cardiovascular Disease: 2008 is a half-day program covering recent advances in the understanding of the pathophysiology and interaction of risk factors in coronary artery disease and cardiovascular disease management. It is designed to provide a review of cardiovascular medicine geared to practicing physicians. Nationally known faculty will present evolving issues and challenges relevant to clinical practice. Key topics include: hypertension, advances in the treatment of heart failure, lipid management, and atherosclerosis in patients with diabetes. The set of lectures will provide a review of established principles of cardiovascular medicine as well as present new concepts and trial-based data in the advancing field of cardiovascular medicine.

In planning this CME activity the National Association for Continuing Education (NACE) performed a needs assessment. A literature search was conducted, national guidelines were reviewed, survey data was analyzed, and experts in each therapeutic area were consulted to determine gaps in practitioner knowledge, competence or performance. Learning objectives (see below), linked to identified gaps, were developed and will be addressed by each presenter. Each participant will be provided with a syllabus containing presentations, clinical tools, and practical guidelines at the start of the program to be used for future reference.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. describe the management of hypertension and the trial data supporting an evidence based approach
2. describe the need for aggressive cholesterol lowering and the value of various therapies
3. understand atherosclerosis in diabetes and techniques for addressing cardiovascular risk reduction
4. recognize and apply recommendations for management of patients with heart failure as they relate to advances in the use of devices for the treatment of heart failure
5. understand the indications for cardiac resynchronization therapy (CRT)

Agenda:

7:15-7:50 am		Registration and Continental Breakfast
7:50-8:00		Welcome Remarks Jose Soler, MD
8:00-9:00		Hypertension - The Evolving Paradigm in 2008 Juan Aranda, MD
9:00-10:00		Advances in the Treatment of Heart Failure - Device Options and the Role of CRT Juan Aranda, MD
10:00-10:30		Break
10:30-11:30		Lipid Management Update W. Virgil Brown, MD
11:30-12:30		Understanding Atherosclerosis in Patients with Diabetes W. Virgil Brown, MD

Faculty:
Juan Aranda, MD
Associate Professor of Medicine
University of Florida College of Medicine
Co-Director Heart Transplant and Heart Failure Program
Shands Hospital, University of Florida
Director Heart Failure/Electrophysiology Fellowship Program

W. Virgil Brown, MD
Charles Howard Candler Professor of Medicine
Emory University School of Medicine Atlanta, Georgia
Chief of Medicine
Atlanta Veterans Affairs Medical Center
Decatur, Georgia

Course Directors: Gregg Sherman, MD and Jose Soler, MD

Activity Director: Michelle Frisch, MPH

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 4.0 Prescribed credits by the American Academy of Family Physicians.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Massachusetts Medical School designates this educational activity for a maximum of 4 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 4.0 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spend in the educational activity.

Policy on Faculty and Provider Disclosure: It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidenced-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are disclosed. Faculty disclosure will be provided in the activity materials.

This program was supported through educational grants from the following companies: AstraZeneca, Boston Scientific, Medtronic, Sorin Group, St. Jude Medical, Takeda.